FDA Approved: ESBRIET — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Esbriet (pirfenidone) filed by Genentech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Esbriet (pirfenidone)

Snippet

SUPPL AP for ESBRIET (PIRFENIDONE)